Harrow Inc
HROW - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.13B
Close$
$13.51
55.1% downside
Current Fair Value
55.1% downsideOvervalued by 55.1% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $1.13 Billion |
|---|---|
| Enterprise Value | $1.36 Billion |
| Earnings per Share | $-0.14 |
| Beta | 0.24 |
| Outstanding Shares | 37,501,971 |
Return
| Return on Equity | -97.60% |
|---|---|
| Return on Assets | -6.43% |
| Return on Invested Capital | -5.71% |
Valuation & Multiples
| P/E Ratio | -39.63 |
|---|---|
| PEG | -4.63 |
| Price to Sales | 3.77 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 4.47 |
| Enterprise Value to EBIT | -72.23 |
| Enterprise Value to Net Income | -48 |
| Total Debt to Enterprise | 0.22 |
| Debt to Equity | 10.31 |
Revenue Sources
No data
Last Earnings Call
Report Date
November 9, 2026
EPS
$0.25
Est. $0.19Revenue
$99.30 M
Est. $98.60 MNext Earnings Call
Expected Date
March 1, 2027
EPS Estimate
$0.56
Consensus analyst estimateRevenue Estimate
$136.52 M
Consensus analyst estimateInstitutional Put/Call Ratio
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.0000▼ 37.17% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 7.77%▼ 50.72% |
|---|---|
| Total Invested | $89.34M▼ 90.34% |
| Investors Holding | 77▼ 157.00% |
About Harrow Health Inc
125 employees
Harrow Health, Inc. owns a portfolio of ophthalmic pharmaceutical businesses, including ImprimisRx, the nation's leading ophthalmology outsourcing facility and pharmaceutical compounding business. The company holds large equity positions...